How decriminalization led to an explosion in cannabis startups (Feat. Ford Smith, Andrew Duffy, and Socrates Rosenfeld) | E2241 - This Week in Startups Recap

Podcast: This Week in Startups

Published: 2026-01-29

Duration: 56 minutes

Guests: Ford Smith, Andrew Duffy, Socrates Rosenfeld

Summary

The episode explores how cannabis decriminalization has spurred industry growth, challenges posed by regulation, and shifting consumer behaviors. It features insights from Ford Smith, Andrew Duffy, and Socrates Rosenfeld on investment, regulation, and market dynamics.

What Happened

The episode opens with an in-depth look at cannabis industry growth, highlighted by Andrew Duffy noting its expansion from a $3 billion to a $30 billion market over a decade, driven by expanding legalization across states. Ford Smith discusses the nuances of hemp legalization via the 2018 Farm Bill, which facilitated creative ways to market THC products under a legal framework.

Andrew Duffy describes the current regulatory landscape's impact on cannabis operators, particularly the inability to deduct business expenses due to cannabis being classified as a Schedule I narcotic. This regulatory burden contrasts sharply with hemp-derived products, which face fewer restrictions and allow for more traditional business models.

The conversation shifts to cultural and market changes, with Socrates Rosenfeld observing a notable decline in alcohol consumption among Gen-Z, who increasingly favor cannabis as a healthier alternative. This shift is corroborated by Gallup's statistics that alcohol consumption has dropped to 54%, while cannabis use has surged.

Ford Smith addresses the economic impact of cannabis legalization, emphasizing that removing tax code 280E could instantly make cannabis businesses profitable. He highlights the hurdles faced by these businesses under the current tax regime and the potential benefits of regulatory reform.

Socrates Rosenfeld compares high-potency cannabis products to moonshine, attributing their rise to prohibition-era regulations that incentivize concentrated forms of cannabis. The discussion touches on the potential health risks of these products and the industry's responsibility to consumers.

The episode closes with a discussion on the future of cannabis in relation to the pharmaceutical industry, where Socrates notes resistance due to the lack of patent opportunities. Additionally, he suggests that cannabis legalization could significantly reduce opioid-related issues, potentially decreasing opioid consumption and deaths by up to 30%.

Key Insights